Rh prophylactic treatment during pregnancy. An attempt to select for treatment those at possible risk.
D000328:Adult; D000906:Antibodies / Q000032:analysis; D001963:Bromelains / Q000494:pharmacology; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D004912:Erythrocytes / Q000187:drug effects; D005260:Female; D005331:Fetomaternal Transfusion; D006801:Humans; D007106:Immune Sera; D007114:Immunization; D007074:Immunoglobulin G; D007231:Infant, Newborn; D010206:Papain / Q000494:pharmacology; D010298:Parity; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System / Q000627:therapeutic use*
D000906:Antibodies; D007106:Immune Sera; D007074:Immunoglobulin G; D012204:Rh-Hr Blood-Group System; D001963:Bromelains; D010206:Papain